Please find below a list of commonly asked questions, as well as Jeff Brown’s responses. We’ll do our best to update this page as a convenience and courtesy to subscribers.
A sincere and heartfelt thank you to everyone who has written in. We receive and read all emails daily.
If the below does not satisfy your question, we welcome your feedback and questions. Please submit your questions here.
As a reminder, Jeff responds to the most common threads and questions in each weekly Ask Me Anything of Outer Limits.
You can find the backlog of questions he’s answered right here…
“Hi Angela, I expected this question would come up a lot, so I’m glad you asked it. The last day of my research/writing was on June 9th, 2023, so unfortunately I lost control over my past portfolios on that day…”
To continue reading, click here.
“While that decision was completely out of my control, I would have maintained that portfolio and continued to provide guidance and updates on the portfolio, as things can change very quickly in the biotech space.”
To continue reading, click here.
“There are fake websites, fake Twitter accounts, and even fake LinkedIn accounts, so please be careful. These are the only accounts I currently have active…”
To continue reading, click here.
“I have never and will never contact any of my subscribers for the purpose of providing any kind of individualized investment advice…”
To continue reading, click here.
“As an employee of MarketWise Research/Legacy Research, I never knew who my subscribers were. I never saw a list of subscribers, ever…”
To continue reading, click here.
“I’m very excited about my forthcoming investment research products. I have a number of new products on my roadmap that I’ve been working on for the last few months…”
To continue reading, click here.
“Do we really think that venture capital and private equity firms will give up their gains and allow their portfolio companies to go public earlier for the benefit of retail investors? Hell no. And that means that we’re going to have to create our own opportunities for private investments.”
To continue reading, click here.
“To hear about his plans to continue this effort, we invite you to watch the following video in Jeff’s own words.”
To view the Brownridge Special Mission video, click here.
“Biotech is one of the industries that I remain most excited about over the next few years…”
To continue reading, click here.
“One of the easiest ways for us to determine that the biotech market is coming back to life is when deals start happening again. I’m happy to say, that time has come.”
To continue reading, click here.
“Our connection was abruptly severed this summer when I stopped writing and publishing my research and analysis. For that, I’m sorry. It was deeply disappointing and heartbreaking for me, and yet it was not my decision…”
To continue reading Jeff’s “Letter to My Old Brownstone Subscribers,” click here.
“As for my departure from Legacy Research and Brownstone Research, it was unfortunately not in my control. On June 9, 2023, I was told I no longer needed to research/write any more. That was it. The most painful part for me is that I lost my connection to my subscribers. We were working through the tough bear market together.”
To continue reading, click here.
